Global burden of obesity in 2005 and projections to 2030
By Tanika N. Kelly, WenJie Yang, Chung-Shiuan Chen, K. Reynolds, Jiang He. International Journal of Obesity, 2008
3,305 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pharmacy, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/2f4480cbf119a96a2f5220da363c4a2ca0f74ec1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pharmacy
In Public Health, Environmental and Occupational Health
- Vasanti S. Malik
- F. B. Hu
- A. Hruby
- Rahman Shiri
- T. I. Sørensen
- Rob Knight
- Jennifer L Baker
- B. Rokholm
Citations in the corpus
- Redox regulation of FoxO transcription factors (2015, background): “By 2030, 573 million adults world-wide are projected to be obese and 366 million individuals may have diabetes [225,226].”
- The Epidemiology of Obesity: A Big Picture (2015, background): “adult population will be overweight and another 20 % will be obese [4].”
- The levelling off of the obesity epidemic since the year 1999 – a review of evidence and perspectives (2010, background): “Furthermore, predictions have been made that if the trend continues, a majority of the world’s adult population will be either overweight or obese by 2030 (5).”
- Sugar-sweetened beverages and risk of obesity and type 2 diabetes: Epidemiologic evidence (2010, background): “A recent pooling analysis from 106 countries indicates that overweight and obesity are indeed significant and increasing public health challenges in most regions of the world including India, China, South East Asia, the Pacific Islands, Latin America, the Middle Eastern crescent, and sub-Saharan Afr”
- Treatment of Obesity with Celastrol (2015, neutral): “It is predicted that more than one billion people in the world will be obese by 2030 (Kelly et al., 2008).”
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans (2010, background): “Although it was originally seen as an issue only in developed nations, current evidence demonstrates an increase in obesity prevalence in many lower- and middle-income countries.([1,2]) In 2005, the WHO estimated the numbers of overweight and obese adults to be 1.”
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies (2011, neutral): “27 However, how these trends will modify the proportional eff ect of diabetes on risk of vascular disease is unclear.”
- Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “The prevalence of overweight and obesity has been expanded dramatically in almost all developing and developed countries, reaching pandemic levels of 60-70% of the adult population in industrialized countries, and being more frequent in females and in urban areas [7,8].”
- The political economy of food systems reform (2017, background): “1 billion people (one person in eight) will be obese (Kelly et al., 2008; Black et al., 2013; Ng et al., 2014).”
- SLEEP DURATION AND DEPRESSION AMONG ADULTS: A META‐ANALYSIS OF PROSPECTIVE STUDIES (2015, neutral): “1 billion by 2030 [1].”